Phase 4 HIV and AIDS Trial, Recruiting (NCT06856174)

Phase 4 HIV and AIDS Trial, Recruiting NCT06856174 Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT06856174 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are living with HIV
People who were assigned female sex at birth
People who are between 40 and 60 years old
People who are in the late stage of perimenopause (the transition leading up to menopause) or in the early stage of postmenopause (shortly after periods have stopped)
People who are experiencing hot flashes and/or night sweats
People who are willing and able to fill in a short diary every day
People who have been taking HIV medication for more than 1 year
People who are not pregnant and are willing and able to use at least a non-hormonal form of birth control during the trial
People who are willing and able to give their formal agreement to participate after talking it through with the research team

Who may not be able to join:

People who have a medical condition that would make hormone therapy unsafe for them
People who are currently taking any medication specifically to treat hot flashes
People who are taking medications that cannot safely be combined with hormone therapy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 301-628-3348

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06856174

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Phase: Phase 4

Status: Recruiting

Condition: HIV and AIDS

Trial contact: 301-628-3348

More information: https://clinicaltrials.gov/study/NCT06856174

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are living with HIV
People who were assigned female sex at birth
People who are between 40 and 60 years old
People who are in the late stage of perimenopause (the transition leading up to menopause) or in the early stage of postmenopause (shortly after periods have stopped)
People who are experiencing hot flashes and/or night sweats
People who are willing and able to fill in a short diary every day
People who have been taking HIV medication for more than 1 year
People who are not pregnant and are willing and able to use at least a non-hormonal form of birth control during the trial
People who are willing and able to give their formal agreement to participate after talking it through with the research team

Who may not be able to join:

People who have a medical condition that would make hormone therapy unsafe for them
People who are currently taking any medication specifically to treat hot flashes
People who are taking medications that cannot safely be combined with hormone therapy

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Registry

ClinicalTrials.gov

Start date

9 April 2026

Est. completion

20 September 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in vasomotor symptoms (VMS) frequency

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov